SANUWAVE Health, Inc.
SNWV
$28.17
-$0.03-0.11%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 88.98% | 53.20% | 53.27% | 27.16% | 18.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 88.98% | 53.20% | 53.27% | 27.16% | 18.89% |
| Cost of Revenue | 62.39% | 59.90% | 25.52% | 81.43% | 22.04% |
| Gross Profit | 99.58% | 50.88% | 67.21% | 12.18% | 17.68% |
| SG&A Expenses | 27.61% | 29.65% | 17.65% | -37.12% | -27.74% |
| Depreciation & Amortization | 10.16% | -3.74% | -3.70% | -1.05% | -1.06% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.07% | 38.09% | 18.82% | -14.48% | -17.55% |
| Operating Income | 467.80% | 113.96% | 46.92% | 171.02% | 78.63% |
| Income Before Tax | 12.84% | 190.35% | 65.38% | 420.26% | -1,980.77% |
| Income Tax Expenses | -- | -- | -- | 100.00% | -- |
| Earnings from Continuing Operations | 12.84% | 190.35% | 65.38% | 420.08% | -1,980.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.84% | 190.35% | 65.38% | 420.08% | -1,980.77% |
| EBIT | 467.80% | 113.96% | 46.92% | 171.02% | 78.63% |
| EBITDA | 930.45% | 89.89% | 51.60% | 207.97% | 88.18% |
| EPS Basic | 34.84% | 144.49% | 82.87% | 262.43% | -1,207.47% |
| Normalized Basic EPS | 34.84% | 108.48% | 83.27% | 266.05% | -1,314.21% |
| EPS Diluted | 34.84% | 137.91% | 82.87% | 244.73% | -1,207.47% |
| Normalized Diluted EPS | 34.84% | 107.23% | 83.27% | 266.05% | -1,314.21% |
| Average Basic Shares Outstanding | 33.77% | 103.08% | 102.13% | 97.05% | 59.14% |
| Average Diluted Shares Outstanding | 33.77% | 138.30% | 102.13% | 97.05% | 59.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
